FR-168888

N/A

Report date: 2026/01/23 17:55:25

NME

Base Information

Drug NameFR-168888

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSodium-hydrogen exchangers inhibitors

TargetsSodium-hydrogen exchangers

Therapy Area/IndicationsMyocardial Ischemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAstellas Pharma Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsMyocardial Ischemia

ATC CodeN/A